# Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis

> **NCT02482129** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 45 (actual)

## Conditions studied

- Acute Anterior Uveitis

## Interventions

- **DRUG:** LME636 60 mg/mL ophthalmic solution
- **DRUG:** Dexamethasone 0.1% ophthalmic solution
- **DRUG:** LME636 Vehicle

## Key facts

- **NCT ID:** NCT02482129
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-17
- **Primary completion:** 2016-03-21
- **Final completion:** 2016-03-21
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482129, "Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02482129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*